Interleukin-15 and Its Soluble Receptor Mediate the Response to Infliximab in Patients With Crohn's Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin-15 and Its Soluble Receptor Mediate the Response to Infliximab in Patients With Crohn's Disease

Published:2010-06 Issue:7 Volume:138 Page:2378-2387
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Bouchaud Gregory,Mortier Erwan,Flamant Mathurin,Barbieux Isabelle,Plet Ariane,Galmiche Jean–Paul,Jacques Yannick,Bourreille Arnaud

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system;Eissner;Cytokine Growth Factor Rev,2004

2. SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production;Friedmann;Nat Cell Biol,2006

3. Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes;Kirchner;Cytokine,2004

4. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha;Mitoma;Gastroenterology,2005

5. Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents;Nesbitt;Inflamm Bowel Dis,2007

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innate Immunity Activation in Newly Diagnosed Ileocolonic Crohn’s Disease: A Cohort Study;Diseases of the Colon & Rectum;2024-02-06

2. Discerning Endoscopic Severity of Inflammatory Bowel Disease by Scoping the Peripheral Blood Transcriptome;Gastro Hep Advances;2024

3. Counteracting Interleukin-15 to Elucidate Its Modes of Action in Physiology and Pathology;Journal of Interferon & Cytokine Research;2023-01-01

4. Interleukin 15 in murine models of colitis;The Anatomical Record;2022-07-28

5. Selective Targeting of IL-15Rα Is Sufficient to Reduce Inflammation;Frontiers in Immunology;2022-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3